Results 1 to 10 of about 7,568,653 (278)
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments [PDF]
Nonalcoholic fatty liver disease (NAFLD) affects approximately 30% of the population worldwide and includes nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis.
Sang Bong Ahn
doaj +3 more sources
Objective: Nonalcoholic fatty liver disease has been connected to coronary artery disease, which is the main cause of mortality. The connection between the degree of nonalcoholic fatty liver disease-induced liver fibrosis and the severity of coronary ...
Tayyip İlker Aydın +3 more
doaj +2 more sources
ANTIOXIDANTS AS POTENTIAL BIOMARKERS OF NONALCOHOLIC FATTY LIVER DISEASE STAGES
Nonalcoholic fatty liver disease is a complex and multifactorial pathology associated with multiple epigenetic, genetic and environmental factors, and its pathogenesis is still not fully understood.
Sofya D. Kravchenko +3 more
doaj +2 more sources
Background/Aims: Nonalcoholic fatty liver disease is considered as the hepatic manifestation of metabolic syndrome. Detection of circulating exosomes together with metabolomic analysis of their cargo would provide early signals for metabolic derangements
Weiyun Jiang +3 more
doaj +2 more sources
Relevant issues in the diagnosis and treatment of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease is a chronic disease uniting steatosis, nonalcoholic steatohepatitis and cirrhosis. Nonalcoholic fatty liver disease is associated with obesity and is a component of metabolic syndrome, thus increasing cardiometabolic ...
E. A. Cherkashina
doaj +2 more sources
Nonalcoholic Fatty Liver Disease
NAFLD likely is the most common liver disease in children and is responsible for significant progression to cirrhosis, portal hypertension, and the need for liver transplantation in adults and even in some adolescents. Early diagnosis and lifestyle interventions appear to be our best hope for controlling progression of disease.
Marcos E, Alfire, William R, Treem
core +4 more sources
Role of nonalcoholic fatty liver disease in hepatocellular carcinoma
Obesity and related disorders are a common cause of morbidity worldwide. Nonalcoholic fatty liver disease is the most important hepatic consequence of adipose accumulation.
Norberto C. Chávez-Tapia +2 more
doaj +2 more sources
Nonalcoholic Fatty Liver Disease [PDF]
AbstractNonalcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of the metabolic syndrome (MetS) and comprises one of the largest health threats of the twenty-first century. In this chapter, we review the current state of knowledge of NAFLD and underline the striking similarities with atherosclerosis.
Ding, Lingling +3 more
openaire +5 more sources
Nonalcoholic fatty liver disease
Management of nonalcoholic fatty liver disease (NAFLD) is crucial for type 2 diabetes (T2D) remission because they are linked through the common pathophysiology of insulin resistance and lipotoxicity. One in three patients with T2D has nonalcoholic steatohepatitis leading to fibrosis, cirrhosis, and hepatocellular carcinoma.
Bebawi, Emmanuel +2 more
openaire +4 more sources
Nonalcoholic Fatty Liver Disease [PDF]
According to the papers published in this special issue, NAFLD is a serious problem, which each author from their own aspect tried to clarify. Regarding the fact that NAFLD is rarely isolated and that it is correlated with obesity, diabetes type 2, polycystic ovarian syndrome, obstructive sleep apnea, and some cognitive deficits, its pathophysiology ...
Branka Filipović +3 more
openaire +7 more sources

